THE USE OF NITROFURANS IN THE TREATMENT OF SEXUALLY TRANSMITTED INFECTIONS.

Main Article Content

F.B. Mirodilova
N.S. Saipova
F.Kh. Abbaskhanova

Abstract

Bacterial vaginosis is not only the cause of unpleasant discharge, but also a risk factor, or even a cause of severe pathology of female genital organs and complications of pregnancy and childbirth. The use of promotes significant improvement in the vaginal microbiota and positive changes in the clinic of bacterial vaginosis.

Article Details

Section

Articles

How to Cite

THE USE OF NITROFURANS IN THE TREATMENT OF SEXUALLY TRANSMITTED INFECTIONS. (2023). Research Focus International Scientific Journal, 2(1), 341-345. https://doi.org/10.66073/researchfocus.v2i1.2876

References

Мартышкина Е.Ю. Неконтрацептивные эффекты гормональной контрацепции. Взгляд российских и зарубежных экспертов. Акушерство, гине-кология и репродук-ция. 2011; 3: 52-54.

Mendling W. Vulvovaginalmykosen. Klinikum Frankfurt (Oder), AkademischesLehrkrankenhaus der Humboldt–Universitat (Charite) zu Berlin. Z ArztlFortbildQualitatssich 1998; 92 (3): 175–9.

Rathod S.D., Klausner J.D., Krupp K., Reingold AL, Madhivanan P. Epidemiologic features of vulvovaginal candidiasis among reproductive-age women in India. Infectious Diseases in Obstetrics and Gynecology; 2012. Article ID 859071, 8 p.

Rylander E., Berglund A.-L., Krassny C., Petrini B. Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse. SexuallyTransmittedInfections. 2004;80:54–57.

Dubini, E., Furnely, P., Antimicrobial activity of nitrofuran. Journal "Italian Chemotherapy", 32, 545., 1985.

Korshunov V.M., Volodin N.N., Efimov B.A. and other Microecology of the vagina. Correction of microflora in vaginal dysbacteriosis. // Textbook. - M., VUNMTs of the Ministry of Health of the Russian Federation, 1999. - 80s.

Mendling, W., Mayland, E., Microbiological and pharmaco-toxicological profile of nitrofuran and its favorable risk/benefit ratio in the treatment of vulvovaginal infections. Drug research. 52, 8 2002.

OAGC (Society of Obstetrics and Gynecology of Canada), Guidelines for Clinical Practice, Committee Recommendation No. 17, March 1997.

Balmer J.A., 1995; Serov V.N., Shapovalenko S.A., 2004.

Urogenital candidiasis. clinical recommendations. RODViK, ROAG, Utl. Ministry of Health of the Russian Federation 2016. M., 2016. 22p. (in Russian).